What is MGRX's market cap?

$4.84M, based on the Nov 3 close of $0.22.

Does Mangoceuticals pay a dividend?

No regular cash dividend has been paid in the last year.

How much of MGRX is sold short?

91.6K shares, 0.5% of float, as of Oct 15, 2026.

What sector is MGRX in?

Healthcare, in the Health Services industry.

NASDAQ · MGRXHealthcareHealth Services

Mangoceuticals, Inc. Common Stock (MGRX)

$0.2180−4.39%

Close Nov 3, 2026 · split-adjusted

Nov 3, 2026$0.22▼ 87.92% in range

Nov 3, 2025Low $0.16 · High $2.21Nov 3, 2026

What changed · written from our data

As of Nov 3, 2026

Mangoceuticals closed at $0.22 on Nov 3, down 4.39%, 90.1% below its 52-week closing high. Volume of 852.4K shares was 1.86× its 20-day average (above normal).

Split-adjusted performance: -47.8% over one month, -31.8% over six months, -89.5% over one year.

In the quarter ended Mar 31, 2026, revenue was $67.86K, down 37.9% from a year earlier, with a net margin of -5447.9%.

Short interest was 91.6K shares at the Oct 15 settlement, down 79.1% from the prior report (0.5% of float, 1.0 days to cover).

Market cap$4.8M22.2M shares

Revenue · quarter$67.9K−37.9% YoY

Diluted EPS$-0.22—

P/E · TTM—P/S 11.7×

Net margin-5,447.9%Gross 87.9%

Dividend yieldNone

52-week range0.16 – 2.21−90.1% from high

Volume852.4K1.86× 20-day avg

Volatility · 60d105.9%Annualised

Short % of float0.5%1.0 days to cover

Net cash$174.6KCash $174.6K

Next earnings—Not scheduled

Split-adjusted performance

1W −12.1%1M −47.8%3M −48.8%6M −31.8%YTD −70.5%1Y −89.5%3Y −98.3%5Y —

Earnings reactions

History →

No reported quarters with price history yet.

Rank within Health Services

Percentile among 20 companies (100 = best)

6-month momentum16

Revenue growth6

Net margin6

Value (low P/E)—

Size11

Industry medians: 6-month return +15.7%, revenue growth +8.5%, net margin 3.0%, P/E 44.5×.

Short interest

Details →

Shares short91.6K−79.1% vs prior

Days to cover1.0Settled Oct 15

% of float0.5%

Short vol. 10d22.8%of daily volume

Closest peers by size in Health Services

Company	Price	Today	6M	Rev. growth	Net margin	P/E	Mkt cap
MGRXMangoceuticals	$0.2180	−4.39%	−31.8%	−37.9%	−5447.9%	—	$4.8M
BRTXBioRestorative Therapies, Inc. Common Stock (NV)	$1.48	0.00%	−70.9%	−7.3%	−9298.3%	—	$2.0M	Compare
PIIIP3 Health Partners	$3.84	−4.00%	+32.9%	+8.6%	−0.6%	—	$15.0M	Compare
ATPCAgape ATP	$1.30	−1.52%	−54.2%	−93.4%	1117.4%	—	$1.3M	Compare
DCGODocGo	$0.2533	+18.36%	−63.0%	−8.7%	−21.5%	—	$25.1M	Compare
CCELCryo-Cell International	$5.05	−5.61%	+43.1%	0.0%	16.2%	—	$40.7M	Compare
EUDAEUDA Health Holdings Limited	$15.91	+2.18%	−2.5%	—	—	—	$47.6M	Compare
PARKPark Dental Partners	$20.30	−1.69%	+15.3%	—	2.0%	—	$96.5M	Compare
VMDViemed Healthcare	$9.46	+0.16%	−2.5%	+23.9%	3.5%	24.8	$360.1M	Compare

News about Mangoceuticals

All news →

Mangoceuticals Secures $2.5 Million Strategic Investment in MangoRx IP Holdings; Receives Initial $1.75 Million TrancheGlobeNewswire Inc. · Oct 1, 2026▲ Positive Mangoceuticals Announces Lawsuit Seeking Damages Exceeding $73 Million Against Former Technology Consulting and Software Development Firm, Clarity Ventures, Inc.GlobeNewswire Inc. · Mar 17, 2026▼ Negative Mangoceuticals, Inc. Announces PCT Patent Filing for MGX-0024 Antiviral Technology to Include Inhibiting Respiratory or Orally Acquired Virus Infection in Animals or BirdsGlobeNewswire Inc. · Mar 6, 2026▲ Positive

Quick answers

What does Mangoceuticals do?: Mangoceuticals Inc focuses on developing, marketing, and selling a variety of men's wellness products and services through a telemedicine platform. The company's platform provides access for customers to a licensed pharmacy for online fulfillment and distribution of certain medications that may be prescribed as part of telehealth consultations, including Mango ED products.
What is MGRX's market cap?: $4.84M, based on the Nov 3 close of $0.22.
Does Mangoceuticals pay a dividend?: No regular cash dividend has been paid in the last year.
How much of MGRX is sold short?: 91.6K shares, 0.5% of float, as of Oct 15, 2026.
What sector is MGRX in?: Healthcare, in the Health Services industry.

About Mangoceuticals

Mangoceuticals Inc focuses on developing, marketing, and selling a variety of men's wellness products and services through a telemedicine platform. The company's platform provides access for customers to a licensed pharmacy for online fulfillment and distribution of certain medications that may be prescribed as part of telehealth consultations, including Mango ED products.

HQ: Dallas, TXListed Mar 21, 2023mangoceuticals.com

Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology